Report in English with a Dutch summary (KCE reports 45A)

228 Screening for Colorectal Cancer KCE reports vol.45
200. Greenwald B. From guaiac to immune fecal occult blood tests: the emergence of
technology in colorectal cancer screening. Gastroenterol Nurs. 2005;28(2):90-6.
201. Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, et al. Guaiac versus
immunochemical tests: faecal occult blood test screening for colorectal cancer in a
rural community. Australian & New Zealand Journal of Public Health.
2005;29(4):358-64.
202. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AVN, Bouvier VM, et al.
Evaluation of an immunochemical fecal occult blood test with automated reading in
screening for colorectal cancer in a general average-risk population. International
Journal of Cancer. 2005;115(3):493-6.
203. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, et al. Performance
characteristics and evaluation of an automated-developed and quantitative,
immunochemical, fecal occult blood screening test. The American journal of
gastroenterology. 2005;100(11):2519-25.
204. Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y. A quantitative immunochemical
faecal occult blood test is more efficient for detecting significant colorectal neoplasia
than a sensitive guaiac test. Alimentary Pharmacology & Therapeutics May.
2006;23(9):1359-64.
205. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z, et al. New immunochemical fecal occult
blood test with two-consecutive stool sample testing is a cost-effective approach for
colon cancer screening: results of a prospective multicenter study in Chinese
patients. International Journal of Cancer. 2006;118(12):3078-83.
206. Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction
during fecal occult blood testing. Eff Clin Pract. 2001;4(4):150-6.
207. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in
colorectal cancer mortality by fecal occult blood screening in a French controlled
study. Gastroenterology. 2004;126(7):1674-80.
208. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial
screening with a faecal occult blood test: results after nine screening rounds. Scand J
Gastroenterol. 2004;39(9):846-51.
209. Heresbach D, Manfredi S, D'Halluin P N, Bretagne JF, Branger B. Review in depth
and meta-analysis of controlled trials on colorectal cancer screening by faecal occult
blood test. Eur J Gastroenterol Hepatol. 2006;18(4):427-33.
210. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized
trial of different screening strategies for colorectal cancer: patient response and
detection rates. Journal of the National Cancer Institute. 2005;97(5):347-57.
211. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled
trial of the impact of intensive patient education on compliance with fecal occult
blood testing. J Gen Intern Med. 2005;20(3):278-82.
212. Thorpe LE, Mostashari F, Hajat A, Nash D, Karpati A, Weber T, et al. Colon cancer
screening practices in New York City, 2003: results of a large random-digit dialed
telephone survey. Cancer. 2005;104(5):1075-82.
213. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening:
The role of patient factors and physician counseling. Preventive Medicine.
2005;41(1):23-9.
214. Wei EK, Ryan CT, Dietrich AJ, Colditz GA. Improving colorectal cancer screening
by targeting office systems in primary care practices: disseminating research results
into clinical practice. Arch Intern Med. 2005;165(6):661-6.
215. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI.
Priorities among effective clinical preventive services results of a systematic review
and analysis. American Journal of Preventive Medicine. 2006;31(1):52-61.
216. Walker A, Whynes DK. Participation and Screening Programmes for Colorectal
Cancer: More Would Be Better? Journal of Health Economics. 1991;10(2):207-25.